While the United States is the home of modern biotechnology, our lead in research and development, innovation, and production of the most cutting-edge biotechnology breakthroughs is slipping. China is pulling ahead, and falling behind in this critical sector puts our economic, food, energy, infrastructure, and national security at risk. In our comprehensive report to Congress, the NSCEB assesses that time is running out to retain and cement our global leadership in biotechnology. We are falling behind fast, and catching back up won’t be an option. This report is not just an assessment of the state of American biotechnology, but an action plan to achieve the greatest heights of discovery and innovation in this sector. We can maintain our advantage in this critical domain, but only if we act now. Read the report here: https://lnkd.in/e9WWcW9w
National Security Commission on Emerging Biotechnology (NSCEB)
Government Administration
Arlington, VA 4,162 followers
Advising the U.S. Government on policy at the intersection of biotechnology + national security.
About us
Congress charged the National Security Commission on Emerging Biotechnology with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense.
- Website
-
https://www.biotech.senate.gov/
External link for National Security Commission on Emerging Biotechnology (NSCEB)
- Industry
- Government Administration
- Company size
- 11-50 employees
- Headquarters
- Arlington, VA
- Type
- Government Agency
Locations
-
Primary
Arlington, VA, US
Employees at National Security Commission on Emerging Biotechnology (NSCEB)
Updates
-
Thank you to Special Competitive Studies Project - SCSP and the 750 people who joined us at the AI+Biotechnology Summit yesterday! This is just the beginning of our work as we chart the future of biotechnology. Now, we begin the work of implementation, starting with the National Biotechnology Initiative Act of 2025, announced Wednesday by NSCEB Congressional Commissioners. https://lnkd.in/esqucyxm
Over the past seven months, the SCSP #AI+Summit series convened over 2,000 attendees from across sectors to explore the intersection of artificial intelligence with Energy, Robotics, Compute/Connectivity, and Biotechnology. 🔋 AI+Energy: 417 attendees joined us for a discussion of the soaring demand of AI on power grids, with keynote speakers Bill Gates, Sen. Brian Schatz, and Dr. Eric Schmidt, pointing to solutions in fusion, nuclear, and geothermal energy. 🤖 AI+Robotics: 363 participants attended a summit on AI’s integration with robotics and the workforce transformation ahead. Anne Neuberger, Marc Raibert, and James Cameron all emphasized the urgent need for national strategy and ethical frameworks. 💻 AI+Compute & Connectivity: 524 guests participated in a discussion on semiconductor security, infrastructure resilience, and U.S. global tech leadership, with insights from Sen. Mark Warner, Dr. Whitney Mason (DARPA), Pat Gelsinger, and Sen. Ted Cruz. 🧬 AI+Biotech: At a final summit in collaboration with National Security Commission on Emerging Biotechnology (NSCEB), 751 attendees joined us, while keynote speakers including Dr. Eric Schmidt, Sen. Todd Young and Ginkgo Bioworks CEO Jason Kelly charted a future of AI-enabled biomanufacturing, inclusive workforce development, and global health leadership. Across the series, three themes stood out: 💡 Cross-sector collaboration 💡Public-private partnerships 💡Urgent, strategic investment in innovation We’re grateful to every attendee, speaker, and partner who made these conversations impactful, and we look forward to building on this momentum at the AI+Expo, June 2nd-4th. Register now! https://expo.scsp.ai/
-
-
Today, NSCEB Congressional Commissioners introduced the first Commission recommendations in Congress. https://lnkd.in/esqucyxm The National Biotechnology Initiative Act of 2025 is designed to catalyze a whole-of-government approach to advancing biotechnology for U.S. national security, economic productivity, and competitiveness. “The United States has long been a leader in biotechnology, but we now risk losing our edge to China. In this era of global competition, we need to promote American biotech innovation and manufacturing. Our legislation will provide a long-term strategy to make federal agencies work together — with greater efficiency — to support American biotechnology.” – NSCEB Chair Senator Todd Young
-
Curious about the future of biotech research and innovation? Hear from NSCEB Chair Senator Todd Young and Dr. Sethuraman Panchanathan, Director of the National Science Foundation, and moderated by Alison Snyder. Register now for the AI+Biotechnology Summit by NSCEB and the Special Competitive Studies Project - SCSP here: https://lnkd.in/eakPqT48
-
-
America’s world-leading capital markets have been our enduring advantage, fueling discovery after discovery. How can we mobilize the private sector to help secure U.S. leadership in biotechnology? Learn more from NSCEB Commissioner Representative Ro Khanna in conversation with Avak Kahvejian. Tomorrow is the AI+Biotechnology Summit, hosted by NSCEB and Special Competitive Studies Project - SCSP. Register here! https://lnkd.in/eakPqT48
-
-
Biotechnology powered by AI will transform just about every aspect of life in the United States. Where does national security fit in? To explore this question and more, join us at the AI+Biotechnology Summit for a Fireside Chat with U.S. Representative and NSCEB Commissioner Stephanie Bice and NSCEB Vice Chair Michelle Rozo in conversation with NSCEB Executive Director Caitlin Gearen Frazer Frazer. Learn more about this summit with Special Competitive Studies Project - SCSP and register to attend here: https://lnkd.in/eakPqT48
-
-
National Security Commission on Emerging Biotechnology (NSCEB) reposted this
I joined Fox News the discuss the critical importance of biotechnology to America’s economic and national security. Please be sure to check out today’s report from the National Security Commission on Emerging Biotechnology (NSCEB) with recommendations on how to bring American innovation to bear on the biotech challenge.
-
Biotechnology will transform how we build defense infrastructure, feed and heal warfighters, optimize logistics, and secure critical supply chains. Hear from panelists Paul Arcangeli, James Mazol, Paul J. Maykish, and Timothy Ray to learn more. Join NSCEB and Special Competitive Studies Project - SCSP for the AI+Biotechnology Summit: https://lnkd.in/eakPqT48
-
-
How will biomanufacturing contribute to broad industrial revitalization in the U.S.? How do we achieve a national biomanufacturing boom? Stop by the AI+Biotechnology Summit on April 10th to find out, with expertise from biotech leaders Robert Conrado, Deepti Tanjore, and Edward Shenderovich moderated by Vivek Chilukuri. Register here: https://lnkd.in/eakPqT48 Special Competitive Studies Project - SCSP
-
-
The U.S. is the home of modern biotechnology and has long been the leader in innovation. But China has made biotech a strategic national priority for 20 years. Who really has the upper hand in biotech and why does it matter? Expert panelists Liza Tobin, Michael Kuiken, and Rush Doshi, moderated by David Lin of Special Competitive Studies Project - SCSP, examine the stakes in this AI+Biotechnology Summit Panel. Register here: https://lnkd.in/eakPqT48
-